Seizure Engram

癫痫发作印迹

基本信息

  • 批准号:
    9979524
  • 负责人:
  • 金额:
    $ 42.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-05-15 至 2023-10-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Epileptic seizures can be characterized as concerted and synchronized activity of neurons across the brain for an extended period of time. We hypothesize that, as for other normal brain-controlled behavior, epileptic seizures are not caused by random activity of neurons, but rather arise from activity in a specific, organized brain network. Our overarching goal is to elucidate such a seizure-specific network in the brain and to deliver genetic neuromodulation specifically to such a seizure-generating network for tailored seizure suppression. In our proposal, we first identify all the critical brain cells that make up that seizure network in acute and chronic rodent models of epilepsy. Then, we will manipulate such a network to stop seizure occurrence. We will identify and visualize brain structures and cells responsible for generation of seizures in the whole brain by labeling these cells with a fluorescent protein tag utilizing sophisticated gene expression techniques in genetically modified mice (Specific Aim 1). This seizure-specific labelling of neurons occurs when they exhibit extensive activity in the presence of a chemical in the system during a seizure episode. This labelling procedure will be repeated to examine if the same neuronal populations become active in two separate episodes of seizures. The cells labeled with the fluorescence reporter will be examined by fluorescence microscopy. Overlapped labelling of neurons between two seizure episodes will support our hypothesis that the same subset of neurons is repeatedly involved in generation of seizures. We will then employ a similar strategy to deliver genetic neuromodulation to a seizure-generating network (Specific Aim 2). We engineered a viral vector that carries a molecular tool that suppress neuronal activity when an activating drug is injected into the animal. This viral vector will be injected into a brain region responsible for generation of seizures in the rodent models of epilepsy we will use. We expect that such manipulation will suppress subsequent seizures. Our hypothesis views and treats epileptic seizures as a network function in the brain. Together with robust network-specific suppression of seizures in mouse models of epilepsy, this will change the way we view and treat this disease.
项目摘要/摘要 癫痫发作的特征是整个大脑中神经元的协调和同步活动 一段较长的时间。我们假设,与其他正常的大脑控制行为一样,癫痫发作 不是由神经元的随机活动引起的,而是由特定的、有组织的大脑网络中的活动引起的。 我们的首要目标是阐明大脑中这种癫痫特异的网络,并将基因 神经调节专门针对这种癫痫发作产生网络,以进行量身定制的癫痫发作抑制。在我们的 建议,我们首先确定构成急、慢性啮齿动物癫痫发作网络的所有关键脑细胞 癫痫模型。然后,我们将操纵这样的网络来阻止癫痫的发生。 我们将识别和可视化在整个大脑中导致癫痫发作的大脑结构和细胞 通过利用复杂的基因表达技术用荧光蛋白标签标记这些细胞 转基因小鼠(特定目标1)。当神经元表现出癫痫发作的特异性标记时,就会出现这种标记 在癫痫发作期间,系统中存在化学物质时的广泛活动。这个贴标签的程序 将重复检查相同的神经元群体是否在两个不同的发作中变得活跃 癫痫发作。标记有荧光报告的细胞将在荧光显微镜下进行检查。 两次癫痫发作之间神经元的重叠标记将支持我们的假设,即相同的子集 神经元反复参与癫痫发作的发生。 然后,我们将采用类似的策略,将遗传神经调节传递给癫痫发作产生网络 (具体目标2)。我们设计了一种病毒载体,它携带一种分子工具,当 一种激活剂被注射到动物体内。这种病毒载体将被注射到负责 我们将在癫痫的啮齿类动物模型中使用癫痫的产生。我们预计,这种操纵将 抑制随后的癫痫发作。 我们的假说将癫痫发作视为大脑中的一种网络功能。与强大的 网络特异性抑制癫痫小鼠模型的发作,这将改变我们看待和 治疗这种疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT E GROSS其他文献

ROBERT E GROSS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT E GROSS', 18)}}的其他基金

Development and validation of a viral vector for targeted inhibition of DG granule cells
用于靶向抑制 DG 颗粒细胞的病毒载体的开发和验证
  • 批准号:
    10648833
  • 财政年份:
    2023
  • 资助金额:
    $ 42.9万
  • 项目类别:
Medical Scientist Training Program
医学科学家培训计划
  • 批准号:
    10706808
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
Data-driven optimization for DBS programming in temporal lobe epilepsy
颞叶癫痫 DBS 编程的数据驱动优化
  • 批准号:
    10574839
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
Medical Scientist Training Program
医学科学家培训计划
  • 批准号:
    10658566
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
Medical Scientist Training Program
医学科学家培训计划
  • 批准号:
    10270489
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
Medical Scientist Training Program
医学科学家培训计划
  • 批准号:
    10875319
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
Medical Scientist Training Program
医学科学家培训计划
  • 批准号:
    10650705
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
Seizure Engram
癫痫发作印迹
  • 批准号:
    10304392
  • 财政年份:
    2020
  • 资助金额:
    $ 42.9万
  • 项目类别:
Development of a self-regulated neuroprotective gene therapy for Parkinsons Disease and other synucleinopathies
开发针对帕金森病和其他突触核蛋白病的自我调节神经保护基因疗法
  • 批准号:
    9809188
  • 财政年份:
    2019
  • 资助金额:
    $ 42.9万
  • 项目类别:
C3 transferase Gene Therapy for CNS Axon Regeneration
用于中枢神经系统轴突再生的 C3 转移酶基因治疗
  • 批准号:
    8873702
  • 财政年份:
    2015
  • 资助金额:
    $ 42.9万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 42.9万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 42.9万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 42.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 42.9万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
  • 批准号:
    2706416
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了